Collegium raises $80M follow-on

Abuse-deterrent analgesics company Collegium Pharmaceutical Inc. (NASDAQ:COLL) raised $80 million through the sale of 5 million shares at $16 in a follow-on underwritten by Jefferies, Piper Jaffray, William Blair, Needham and Janney Montgomery Scott. The price represents a 5% discount to Collegium's $16.87 closing price on Tuesday, when the company announced the offering after market hours. Collegium sank $1.25 to $15.62 on Wednesday. ...